MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells

Life Sciences

Volumn 82, Issue 9-10, 2008, Pages 519-528

  Lenoir, Christelle ^a   Sapin, Catherine ^a   Broquet, Alexis H ^a   Jouniaux, Anne Marie ^a   Bardin, Sabine ^a   Gasnereau, Isabelle ^a   Thomas, Ginette ^a   Seksik, Philippe ^a   Trugnan, Germain ^a   Masliah, Joëlle ^a   Bachelet, Maria ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Caco 2; Cox 2; HT29; PGE2; SW837; TLR4

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 2; GLYCOPROTEIN; INTERLEUKIN 8; PROSTAGLANDIN E2; PROTEIN MYELOID DIFFERENTIATION 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTESTINE EPITHELIUM CELL; NONHUMAN; PROTEIN EXPRESSION;

ANTHRACENES; CACO-2 CELLS; CELL LINE, TUMOR; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPITHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION; HT29 CELLS; HUMANS; IMIDAZOLES; INTERLEUKIN-8; INTESTINES; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 39149129371     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.12.007     Document Type: Article

References (28)

1. Abreu M., Vora P., Faure E., Thomas L.S., Arnold E.T., and Arditi M. Decreased expression of toll-like receptor 4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. Journal of Immunology 167 (2001) 1609-1617
2. Cario E., Golenbock D.T., Visintin A., Runzi M., Gerken G., and Podolsky D.K. Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance. Journal of Immunology 176 (2006) 4258-4266
3. Da Silva Correia J., Soldau K., Christen U., Tobias P.S., and Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. Journal of Biological Chemistry 276 (2001) 21129-21135
4. Duchmann R., Kaiser I., Hermann E., Mayet W., Ewe K., and Meyer zum Buschenfelde K.H. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clinical and Experimental Immunology 102 (1995) 445-447
5. Dziarski R., Wang Q., Miyake K., Kirschning C.J., and Gupta D. MD-2 enables toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to gram-negative bacteria and their cell wall components. Journal of Immunology 166 (2001) 1938-1944
6. Hornef M.W., Frisan T., Vandewalle A., Normark S., and Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. Journal of Experimental Medicine 195 (2002) 559-570
7. Kakiuchi Y., Tsuji S., Tsujii M., Murata H., Kawai N., Yasumaru M., Kimura A., Komori M., Irie T., Miyoshi E., Sasaki Y., Hayashi N., Kawano S., and Hori M. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Research 62 (2002) 1567-1572
8. Komatsu K., Buchanan F.G., Katkury S., Morrow J.D., Inoue H., Otaka M., Watanabe S., and DuBois R.N. Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2. Gastroenterology 129 (2005) 577-590
9. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews 81 (2001) 807-869
10. Medvedev A.E., Lentschat A., Wahl L.M., Golenbock D.T., and Vogel S.N. Dysregulation of LPS-induced toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin tolerant cells. Journal of Immunology 169 (2002) 5209-5216
11. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophilla Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
12. Mullen G.E.D., Kennedy M.N., Visintin A., Mazzoni A., Leifer C.A., Davis D.R., and Segal D.M. The role of disulfide bonds in the assembly and function of MD-2. Proceedings of the National Academy of Sciences USA 100 (2003) 3919-3924
13. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., and Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nature Immunology 3 (2002) 667-672
14. O'Neill L.A.J., and Dinarello C.A. The IL-1 receptor/toll-like receptor superfamily:crutial receptors for inflammation and host defense. Immunology Today 21 (2000) 206-209
15. Otte J.M., Cario E., and Podolsky D.K. Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 128 (2004) 1054-1070
16. Potter J.D., and Ulrich C.M. Cox-2 and gastric cancer: more on inflammation and neoplasia. Gastroenterology 130 (2006) 2198-2200
17. Pugin J., Stem-Voeffray S., Daubeuf B., Matthay M.A., and Elson G. Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood 104 (2004) 4071-4079
18. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., and Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4. Journal of Experimental Medicine 189 (1999) 1777-1782
19. Simmons D.L., Botting R.M., and Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacological Reviews 56 (2004) 387-437
20. Smith J.L., Schaffner A.E., Hofmeister J.K., Hartman M., We G., Forsthoefel D., Hume D.A., and Ostrowski M.C. ets-2 is a target for an akt (protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice. Molecular and Cellular Biology 20 (2000) 8020-8034
21. Swantek J.L., Cobb M.H., and Geppert T.D. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Molecular and Cellular Biology 17 (1997) 6274-6282
22. Sweet M.J., and Hume D.A. Endotoxin signal transduction in macrophages. Journal of Leukocyte Biology 60 (1996) 8-26
23. Tak P.T., and Firestein G.S. NF-kB: a key role in inflammatory diseases. Journal of Clinical Investigation 107 (2001) 7-11
24. Tsujii M., Kawano S., and DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proceedings of the National Academy of Sciences USA 94 (1997) 3339-3340
25. Ulevitch R.J., and Tobias P.S. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Current Opinion in Immunology 11 (1999) 19-22
26. Visintin A., Mazzoni A., Spitzer J.A., and Segal D.A. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to toll-like receptor 4. Proceedings of the National Academy of Sciences USA 98 (2001) 12156-12161
27. Wadleigh D.J., Reddy S.T., Kopp E., Ghosh S., and Herschman H.R. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. Journal of Biological Chemistry 275 (2000) 6259-6266
28. Yang H., Young D.W., Gusovsky F., and Chow J.C. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. Journal of Biological Chemistry 275 (2000) 20861-20866